Oxurion NV (XBRU:OXUR) Gross Margin % : 7.23% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Oxurion NV Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Oxurion NV's Gross Profit for the six months ended in Dec. 2023 was €0.01 Mil. Oxurion NV's Revenue for the six months ended in Dec. 2023 was €0.08 Mil. Therefore, Oxurion NV's Gross Margin % for the quarter that ended in Dec. 2023 was 7.23%.

Warning Sign:

Oxurion NV gross margin has been in long-term decline. The average rate of decline per year is -9.6%.

The historical rank and industry rank for Oxurion NV's Gross Margin % or its related term are showing as below:

XBRU:OXUR' s Gross Margin % Range Over the Past 10 Years
Min: 3.15 Med: 44.25 Max: 73.53
Current: 39.54

During the past 13 years, the highest Gross Margin % of Oxurion NV was 73.53%. The lowest was 3.15%. And the median was 44.25%.

XBRU:OXUR's Gross Margin % is ranked worse than
70.42% of 737 companies
in the Biotechnology industry
Industry Median: 59.43 vs XBRU:OXUR: 39.54

Oxurion NV had a gross margin of 7.23% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Oxurion NV was -9.60% per year.

Oxurion NV Gross Margin % Historical Data

The historical data trend for Oxurion NV's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Gross Margin % Chart

Oxurion NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

42.75

73.53

45.74

13.78

39.54

Oxurion NV Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Margin %	Get a 7-Day Free Trial															54.72	39.23	-5.97	54.44	7.23

Competitive Comparison of Oxurion NV's Gross Margin %

For the Biotechnology subindustry, Oxurion NV's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxurion NV's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxurion NV's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Oxurion NV's Gross Margin % falls into.

Oxurion NV Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Oxurion NV's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	0.1	/	0.263
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.263 - 0.159)	/	0.263
	=	39.54 %

Oxurion NV's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	0.083
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.083 - 0.077)	/	0.083
	=	7.23 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Oxurion NV (XBRU:OXUR) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Oxurion NV had a gross margin of 7.23% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Oxurion NV Gross Margin % Related Terms

Thank you for viewing the detailed overview of Oxurion NV's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxurion NV (XBRU:OXUR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (XBRU:OXUR) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

TG4:Germany

Address

Gaston Geenslaan 1, Leuven, BEL, B-3001

Website

https://www.oxurion.com

Oxurion NV is a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME). The Group's research and development facilities are located in Belgium .The Company is engaged in the development of drugs to treat back-of-the-eye diseases, more specifically, ophthalmologic pharmaceuticals to treat vascular retinal disorders, specifically DME.

Oxurion NV (XBRU:OXUR) Headlines

No Headlines